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Abstract
Background: Health care workers (HCW) are at high risk for developing occupational hand dermatitis (HD) due to
frequent exposure to ‘wet work’. Amongst HCWs, nurses are at highest risk, with an estimated point prevalence of
HD ranging between 12 and 30%. The burden of disease is high with chronicity, sick leave, risk of unemployment
and impaired quality of life. Despite evidence from the medical literature on the risk factors and the importance of
skin care in the prevention of HD, in practice, compliance to skin care protocols are below 30%. New preventive
strategies are obviously needed.
Methods/design: This is a cluster randomized controlled trial, focusing on nurses performing wet work. In total, 20
wards are recruited to include 504 participating nurses in the study at baseline. The wards will be randomized to an
intervention or a control group and followed up for 18 months.
The intervention consists of the facilitation of creams being available at the wards combined with the continuous
electronic monitoring of their consumption with regular feedback on skin care performance in teams of HCWs.
Both the intervention and the control group receive basic education on skin protection (as ‘care as usual’). Every
6 months, participants of both groups will fill in the questionnaires regarding exposure to wet work and skin
protective behavior. Furthermore, skin condition will be assessed and samples of the stratum corneum collected.
The effect of the intervention will be measured by comparing the change in Hand Eczema Severity Index (HECSI
score) from baseline to 12 months. The Natural Moisturizing Factor (NMF) levels, measured in the stratum corneum
as an early biomarker of skin barrier damage, and the total consumption of creams per ward will be assessed as a
secondary outcome.
Discussion: This trial will assess the clinical effectiveness of an intervention program to prevent hand dermatitis
among health care workers
Trial registration: Netherlands Trial Register (NTR), identification number NTR5564. Registered on 2 November 2015.
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Background
Health care workers (HCW) are at high risk for develop-
ing occupational hand dermatitis (HD) due to frequent
exposure to ‘wet work’ [1]. Wet work, defined as unpro-
tected exposure to humid environments/water; high fre-
quency of hand-washing procedures or prolonged glove
occlusion, is believed to cause irritant contact dermatitis
in a variety of occupations [2]. Despite there being no
clear scientific definition for wet work in terms of expos-
ure frequency, duration or intensity; most study groups
refer to regulatory guidelines. For example, the German
guidelines, in which wet work is defined as having wet
hands for more than 2 h per regular work day (per shift),
hand-cleansing more than 20 times per day or the wear-
ing of occlusive gloves for 2 h per day [3].
Amongst HCWs, nurses are particularly at high risk of
HD, with an estimated point prevalence of 12–30% [4, 5].
Almost 60% of HCWs are reported to have eczema-
related sick leave during the first year after notification of
the disease [6]. This makes the burden of disease high for
affected individuals as well as in the socioeconomic con-
text. The total annual costs for occupational skin diseases
for medical care, absenteeism and disability pensions are
estimated to be €98 million in The Netherlands [7].
Recently, infection prevention policy in The Netherlands
has become stricter, with emphasis on the frequent use of
hand alcohol and hand washing with soap to prevent trans-
mission of infections. This has led to an increase in expos-
ure to irritants and a higher risk of skin barrier damage.
In The Netherlands, the Dutch Society of Occupa-
tional Medicine (NvAB) established guidelines for the
prevention of occupational hand dermatitis (OHD) in
2006 [8]. The guideline stresses the importance of the
maintenance of an uncompromised skin barrier for the
prevention of HD and recommends regular use of skin
care products such as emollients and ointments. A more
recent update of contact dermatitis guidelines from The
Netherlands Society of Dermatology and Venereology
(NVDV) [9] consistently recommended the use of emol-
lients to help prevent irritant contact dermatitis, refer-
ring to three studies [10–12]. The findings from one
RCT showed that the use of creams decreased occupa-
tional hand dermatitis, compared to the control without
any intervention [11]. In another RCT, healthy volun-
teers washed their hands 15 times a day, after which
they used cream. Compared with the control group, skin
hydration was significantly higher in the group which
used creams [10]. In an experimental study by Kampf et
al. [12], a test group comprising 25 subjects applied
hand creams after every hand wash. The result was that
the use of hydrating creams decreases the symptoms of
HD including skin hydration and skin roughness. Several
skin care programs have been effectively introduced in
the health care setting to help prevent occupational
diseases [13, 14]. The effectiveness of these programs
seemed to depend on three factors: (1) the effectiveness
of protective measures (i.e. skin care products), (2) the
adherence to these measures (i.e. frequency of applica-
tion) and (3) the effectiveness of education on preventive
behavior (by raising awareness about the risk factors for
HE and the importance of protective measures) [15].
Moisturizers belong to the most widely used prepara-
tions to decrease dryness and improve skin barrier func-
tion. The effects of moisturizers on the skin barrier has
mainly been investigated in several experimental irrita-
tion studies [16, 17]. A number of different mechanisms
behind the barrier-improving effects of various creams
have been suggested, but still their mechanisms are not
fully understood.
With respect to the effectiveness of education, several
intervention studies have shown moderate evidence that
education influences behavior, which leads to a reduc-
tion in skin symptoms [18]. Regarding the second factor,
despite evidence from interventions that consider appro-
priate skin care effective, the adherence to these prevent-
ive measures in the workplace remains low [19].
Recently, an electronic monitoring system has been
developed for the continuous registration of hand cream
consumption and data recording. This system enables a
detailed feedback to HCWs on the frequency with which
the hand cream is used as well as when it is used. In
hand hygiene studies, a similar monitoring system was
earlier proven to improve compliance by 42% [20]. Mon-
itoring and feedback are widely used as a strategy to im-
prove professional performance and patient outcomes
[21]. The effects are generally moderate and vary based
on the way that the intervention is designed and deliv-
ered [22]. Feedback is suggested to be more effective to
improve performance when: (1) baseline performance is
low, (2) when the source is a supervisor, (3) when it is
provided more than once and (4) when it is provided
both verbally and in written form [22]. Group monitor-
ing is widely recognized as being more effective than
other monitoring systems that track individuals’ actions
which can be seen by staff as punitive or an invasion of
their privacy [23]. Providing group data to units has
been shown to encourage group collaboration in a posi-
tive manner as staff work together to improve compli-
ance, resulting in better and more sustained results.
In the present study, we aim to investigate the effective-
ness of such a feedback-monitoring system combined with
raising awareness in a randomized controlled trial (RCT).
The intervention will comprise of the placing of hand
cream dispensers on the wards, electronic monitoring of
their use, and repeated feedback to the HCWs on the
wards. The efficacy will be assessed by measuring skin
conditions in HCWs before and after the intervention,
compared with a control group.
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Objectives
We will investigate whether an intervention program,
based on the provision of hand creams and regular feed-
back on cream consumption, can improve the skin condi-




A two-arm, single-blinded, cluster RCT, based on hospital
wards as the unit of randomization. The aim is to recruit
wards and then randomly allocate them to an intervention
or a control group after stratification on exposure to wet
work. The follow-up is 18 months. The primary means of
data collection will consist of two assessments (one clin-
ical and the other biochemical), questionnaires and elec-
tronic consumption records.
Trial setting
The trial will take place at a large medical academic center
in The Netherlands, the VUmc (Free University Medical
Center), with a total of 45 departments of which approxi-
mately 20 are clinical wards.
The investigators are responsible for the protocol, the
conducting of the trial, analysis of the data and all other
aspects involved.
Recruitment of participants
The trial includes nurses engaged in wet work activities
(e.g. hand washing, use of hand disinfectants, wearing
gloves) on clinical wards of the VUmc. The identification
of the ‘high-risk wards’ will be based on the consump-
tion of soap and disinfectants per ward (normalized for
number of HCW/ward). Wards where nurses have an
increased risk of HD due to the nature of their work are
defined as ‘high risk’. For recruitment, the manager re-
sponsible for a ward will receive a letter from the inves-
tigators stating the purpose of the study, a short version
of the study protocol, and a brief description of the ex-
pected burden for the participant during the interven-
tion. On the wards which are willing to participate, the
researcher will give a short presentation on HD in
HCWs and the preventive measures as described in the
Dutch guidelines [8, 9]. During the presentation, the re-
searcher will also inform the participants about the study
and provide leaflets with study outlines. Furthermore,
the HCW will be given an application form with contact
details in which they can express their interest to partici-
pate in the study. The investigator will distribute the pa-
tient information letter on the wards and invite the
interested participants for a visit. Nurses agree to partici-
pate by signing a Consent Form.
Products used in the intervention group
In the electronic dispensers, placed on the intervention
wards, Stokoderm® Aqua Sensitive will be used; a white,
perfume- and silicone-free soft cream, with no particular
pharmacological function. The main ingredients are gly-
cerol and urea, which are known to prevent loss of water
leading to dry skin.
Inclusion criteria
 Willing to give informed written consent
 Age 18 to 65 years
 Having daily exposure to wet work activities during
work
 Being employed as nurse or nutrition assistant on
the participating wards
Exclusion criteria
Being employed on more than one ward
Description of the study procedures and intervention
The flowchart of the study design is shown in (Fig. 1).
After inclusion, the participants will fill in the baseline
questionnaire and undergo baseline measurements (clin-
ical scoring and stratum corneum (SC) collection). The
baseline questionnaire includes information on partici-
pants’ characteristics (including number of working
hours, and years of employment), history of atopic dis-
eases, relevant medical history, skin condition and the
risk factors/exposures (self-reported average frequency
of hand washing, use of hand disinfectants, use of skin
care products and gloves during a shift). Filling in the
questionnaires will take approximately 3–5 min per
participant.
Both the intervention and the control group will re-
ceive basic education on skin protection (as ‘care as
usual’). These educational courses will be given on each
ward every 3 months from baseline to the end of study.
Our group education program (as described in Table 1)
will comprise basic knowledge about the skin, the devel-
opment of eczema and recommendation for skin protec-
tion, and care as proposed by the NVAB guidelines for
contact dermatitis [8] (Table 2).
At baseline and 12 months after baseline, the participants
in both groups will undergo clinical measurements (Hand
Eczema Severity Index (HECSI) scoring), SC samples will
be collected for Natural Moisturizing Factor (NMF) ana-
lysis and the participants will fill in the questionnaire.
Participants in the control group (just as in the inter-
vention group) with severe eczema requiring medical
treatment will be advised to consult the occupational
physician or dermatologist.
Additional procedure in the intervention group:
Soltanipoor et al. Trials  (2017) 18:92 Page 3 of 8
After randomization into the intervention group, the
hand cream (Stokoderma® Aqua Sensitive) will be pro-
vided in electronic dispensers (with monitoring system)
on the wards at places which are easily accessible. At
least five dispensers per ward will be located at sinks, at
the entrance and exit of each ward and other relevant
places such as in coffee rooms and toilets. The provided
hand cream is commercially available and is widely used
in the health care sector.
Each dispenser records continuously each application
event, providing information on the timing and fre-
quency of use of hand creams during the working shift.
The system provides robust and easy to interpret web-
based reports on cream use per dispenser. Data on use
pattern (frequency, total consumption, moments of use)
and trends will enable a structured feedback on hand
cream use to the nurses and management to motivate
and improve compliance. Feedback sessions on hand
Fig. 1 Flowchart for the Healthy Hands Project (HHP). The HHP trial will run for 18 months in total, though the primary and secondary outcomes
will be assessed after 12 months, during the second and last visit
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cream use will be done every 6 months after baseline
during regular meetings of the nursing staff and per-
formed by the head nurse.
Outcome measures
Primary outcome
The change in disease severity as assessed by the Hand
Eczema Severity Index (HECSI) score.
This validated scoring system, the HECSI [24], grades
the intensity of erythema, induration, papules, vesicles,
fissures, scaling and oedema for five areas of each hand
(fingertips, fingers, palms, back of hands, wrists) on a
scale from 0 (not present) to 3 (severe). The extent of af-
fected skin in each area is graded from 0 to 4. The total
index score with a range from 0 to 360 is then found by
multiplying the intensity with the extent [24]. The
HECSI will be assessed at baseline and after 12 months
in both the intervention and the control group.
Secondary outcomes
The change in levels of NMF in the skin as a marker of
early signs of barrier damage.
NMFs are mainly composed of the breakdown prod-
ucts of epidermal protein filaggrin. NMFs play an im-
portant role for the skin barrier function as they
contribute to skin hydration, the maintenance of the
acidic pH of the skin, and the epidermal inflammatory
response [25]. Recently, it has been shown that various
skin irritants significantly reduce the levels of NMF [26].
One study showed that during cleansing (and more than
10-min water contact) large quantities of NMF can leach
from the skin surface, leading to dry skin and, by repeti-
tive exposures to skin barrier damage, to inflammation
[27]. Therefore, the NMF levels might reflect early dam-
age of the skin barrier.
The NMF levels will be determined in the uppermost
layers of the skin, the stratum corneum (SC). The SC sam-
ples will be harvested by using adhesive tape strips, a
method which is extensively used in experimental studies
[28]. Briefly, round adhesive tape discs (3 × 8 cm2, D-
Squame; CuDerm, Dallas, TX, USA) will be attached to the
skin of the right hand. Each tape is pressed onto the volar
aspect of the hand for 10 s with standardized force, using a
disc pressure applicator (CuDerm, Dallas, TX, USA). The
first four successive strips from the same skin site will be
discarded and for the NMF analysis the fifth to seventh tape
strips will be collected. The tape strips are gently removed
with tweezers and stored in a closed vial at −20 °C until
analysis. For the analysis of NMF in tape strips, NMF con-
stituents will be extracted from the tape strips using 40%
ammonia and subsequently analysed by HPLC-UV [29]. To
compensate for variable amount of SC harvested by a tape,
the protein amount will be determined on each tape by
measuring optical density (SquameScan, CuDerm, Dallas,
TX, USA). NMF concentration on the tape will be normal-
ized by the protein amount.
Process outcomes
Individual consumption of hand creams (application fre-
quency/per shift) will be assessed by questionnaires at
baseline and every 6 months from baseline.
Total consumption of creams in the intervention
group will be measured by real-time monitoring per
ward as a secondary outcome and compared over time.
Skin exposure to irritants
Individual exposure will be assessed by questionnaires
(estimated frequency of soap and alcohol use per shift),
completed every 6 months. Furthermore, exposure per
ward will be estimated from data on the purchase of
soap and disinfectants.
Sample size
This trial is planned to include 544 individuals. The sample
size is based on a previous study, in which the Osnabruck
Hand Eczema Severity Index score after 12 months’
follow-up in the control group was 0.1 points with a stand-
ard deviation of 1.2. A difference in the Osnabruck Hand
Eczema Severity Index score of 0.4 points is clinically sig-
nificant [30]. Using a two-sided t test with a significance
level of 0.05, we calculated that a study with 17 clusters per
treatment group with 16 individuals per cluster would have
81% power to detect a difference of 0.4 in group means
when the standard deviation is 1.2 and the intracluster cor-
relation is 0.05.
Table 1 Educational program
Methods
-Educational courses every 3 months
-Booklet on preventive measures
Program topics
-What is hand eczema and what are the symptoms?
-Risk factors of hand eczema
-Consequences of hand eczema
-Preventive measures
Table 2 Main recommendations for the prevention of hand
dermatitis (NVAB guideline, 2006) [8]
1. Use disinfectants instead of water and soap to disinfect the
hands, when hands are not visibly dirty
2. Wear gloves when performing wet work
3. Wear cotton under-gloves when you wear gloves for longer than
10 min
4. Use a moisturizer on a daily basis to nurse the skin
5. Creams should be applied over the whole hand, including the
webs, fingertips and dorsal aspects
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Randomization
The method of fixed-block randomization will be used
to carry out randomization with block sizes of 2. The
blocks (one high-exposure block and one low-exposure
block) will be stratified by exposure to wet work, esti-
mated from the purchase of soaps per ward. Two blocks
will be randomized at a time to reduce bias and achieve
balance in the allocation of participants to the interven-
tion or control arm. Randomization will be performed
prior to baseline collection.
The investigator, assessing the clinical outcomes, will
be blinded with respect to treatment allocation until
after analysis.
Statistical methods and data analysis
We will use state-of-the-art methods to deal with
missing data and statistical methods to analyse our
data and publish a full statistical analysis plan before
the researchers are unblinded. When reporting the re-
sults of this study, we will adhere to the Consolidated
Standards of Reporting Trials (CONSORT) Statement
[31] and its extensions on the reporting of patient-
reported outcomes in randomized trials [32] and on
cluster randomized trials [33].
Blinding
The investigator, assessing the clinical outcome, will be
blinded with respect to treatment allocation. It is not
possible to blind the participants.
Participants’ withdrawal
Subjects are free to leave the study at any time for any
reason if they wish to do so, without any consequences.
The investigator can decide to withdraw a subject from
the study for urgent medical reasons.
Finance and insurance
The trial is (partly) financed by an unrestricted grant from
the company DEB, which covers all expenses related to
the study. The participants in the study are covered by
their work insurance.
Fig. 2 Summary of the Healthy Hand Project (HHP) trial assessments performed at different time points
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Discussion
The overall purpose of the Healthy Hands Project is to
change the behavior of HCWs towards hand care and
make skin care part of the work culture. We look at HD
among nurses, who are known to have an increased risk
of occupational hand eczema due to wet work. We focus
on the facilitation of cream availability combined with
the continuous monitoring of its consumption with
regular feedback on skin care performance in HCWs,
aimed at improving their preventive behavior. In
addition, this trial will provide information on the actual
degree of exposure to wet work in HCWs in The
Netherlands, which is important for focused prevention.
The intervention is general, straightforward and, there-
fore, easy to implement in health care institutions. The
results of this study will help to gain insight into the ef-
fectiveness of our intervention program on skin condi-
tion and, secondarily, on the consumption of hand
creams. We will provide relevant data on the current use
of moisturizers in practice in health care work environ-
ments and the efficacy of an intervention which is rela-
tively easy to implement.
Currently, a multicenter intervention RCT, which in-
vestigates a range of interventions aimed at the reduc-
tion of hand dermatitis among nurses, is running in the
UK (the SCIN trial) [34]. In contrast to our study, the
SCIN trial focuses on behavioral change to improve
hand care, based on the theory of planned behavior and
implementation intentions. The impact of the interven-
tions will be assessed via questionnaires and standard-
ized photographs of hands/wrists, and the primary
outcome parameter will be the change in point preva-
lence of visible hand dermatitis from baseline to
12 months after the intervention. In the present study,
the changes in the skin condition between control and
intervention groups are used as the primary outcome.
The skin condition will be assessed by clinical scoring
(HECSI score) performed by a trained physician. In
addition, we include as a secondary outcome the NMF
levels, which might be a more sensitive parameter of the
skin damage than clinical scoring.
With an RCT design, the risks of selection bias will be
reduced, and random and design errors limited [30].
The risk of bias will be further reduced by conducting a
central randomization stratified for exposure to soaps as
an important prognostic factor. We blinded the outcome
assessors to minimize the risk of detection bias. In order
to limit contamination, the control group will not re-
ceive information about the existence of an intervention
group or the purpose of the study [35]. It must be ac-
knowledged, however, that a risk of contamination bias
cannot entirely be avoided because the participants work
in the same medical center and could find out about the
intervention group.
Strong points: real-time monitoring of consumption of
creams, objective assessment of the skin condition, fa-
cilitation of creams, feedback on performance, and de-
termining NMF levels to detect early signs of skin
barrier damage.
Drawbacks: self-reported hand cream use to assess indi-
vidual use of skin care in both the control group and the
intervention group. The objective data on cream use in the
intervention group are ward-based. Exposure estimates are
ward-based and self-reported at the individual level.
Trial status
Recruitment into this trial started in June 2016 and is
taking place in the VU Medical Center in Amsterdam.
Patient recruitment has not been completed at the time
of submission.
Additional file
Additional file 1: Completed SPIRIT Checklist. (DOC 121 kb)
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